multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacyand safety of iptacopan (LNP023) in idiopathic immune complex mediated membranoproliferativeglomerulonephritis (IC-MPGN).

Project: Research project


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.


Medicine and Dentistry